Population Genomics Insights into Pharmacogenomic Differentiation Between East Asians and Europeans

Clinical Pharmacology and Therapeutics · Published 2026-06-03 · DOI 10.1002/cpt.70354

Free full text

Authors (3)

Sihan Chen, Hongpu Chen, Shuhua Xu

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Chen, S., Chen, H., Xu, S. (2026). Population Genomics Insights into Pharmacogenomic Differentiation Between East Asians and Europeans. Clinical Pharmacology and Therapeutics. https://doi.org/10.1002/cpt.70354

Related articles

• Clinical Pharmacology at the Point of Decision · Clinical Pharmacology and Therapeutics · 2026 · Cites or is cited by this article · Same journal
• Fecal Microbiota Transplantation and Microbiota‐Based Therapeutics in Allogeneic Hematopoietic Stem Cell Transplantation: Current Evidence and Future Directions · Clinical Pharmacology and Therapeutics · 2026 · Same journal
• Identification of a Functional CYP2C8 Variant Allele that Alters Splicing, Reduces Protein Expression, and Increases Drug Exposure · Clinical Pharmacology and Therapeutics · 2026 · Same journal
• ASCPT News · Clinical Pharmacology and Therapeutics · 2026 · Same journal
• Reframing the Landscape for Achieving Equitable Pharmacotherapy Health Outcomes: Introducing Pharmacogenequity · Clinical Pharmacology and Therapeutics · 2026 · Same journal
• The Multiple Criteria Qualitative Value‐Based Pricing Framework “ MARIE ” for Novel Cell and Gene Therapy · Clinical Pharmacology and Therapeutics · 2026 · Same journal
• In This Issue · Clinical Pharmacology and Therapeutics · 2026 · Same journal
• From Non‐Cancer Pain to Cancer Survivorship: Applying Opioid Deprescribing Lessons across the Divide · Clinical Pharmacology and Therapeutics · 2026 · Same journal
• Ruxolitinib Pharmacokinetics and Exposure–Toxicity Relationship in Hematologic Malignancies and Immune‐Mediated Diseases: A Prospective Observational Study · Clinical Pharmacology and Therapeutics · 2026 · Same journal
• Early and High‐Dose Glucocorticoid Use and Survival in Advanced NSCLC Receiving Immune Checkpoint Inhibitors: A Multicenter Target Trial Emulation · Clinical Pharmacology and Therapeutics · 2026 · Same journal